CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01963143
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:38.195366+00:00
Published At: 2017-03-29T00:00:00+00:00
Record Updated At: 2017-03-29
Results Posted At: 2017-03-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Immune Deficiency Disorders", "Common Variable Immunodeficiency", "X-linked Agammaglobulinaemia", "Hyper-IgM Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-03-29"
protocolSection.identificationModule.nctId: "NCT01963143"
protocolSection.identificationModule.officialTitle: "A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex\u00ae 10 and Gammaplex\u00ae 5% in Primary Immunodeficiency Diseases"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-03-29"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.